[ Price : $8.95]
FDA launches a new effort to aggregate clinical trial data on kidney safety biomarkers, seeking pharmaceutical industry participat...[ Price : $8.95]
FDA issues an early alert warning healthcare providers about a potentially high-risk defect affecting certain infant resuscitation...[ Price : $8.95]
PhRMA calls on FDA to provide clearer regulatory expectations for the use of digital health technologies in drug development, argu...[ Price : $8.95]
FDA approves an expanded indication for Pfizer's hemophilia treatment Hympavzi (marstacimab-hncq), allowing its use in additional ...[ Price : $8.95]
Stakeholders at FDA's public hearing on the Commissioners National Priority Voucher program urge the agency to temporarily suspend...[ Price : $8.95]
The House passes FDAs appropriations bill for fiscal year 2027 that provides $7.1 billion for the agency.[ Price : $8.95]
FDA issues Xspray Pharma a complete response letter for the company's NDA for Nilopki, an improved formulation of nilotinib design...[ Price : $8.95]
FDA says its breakthrough devices program has surpassed 1,280 designations since its launch, highlighting the growing use of the e...